Johnson & Johnson (JNJ)
Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly
Eli Lilly (NYSE:LLY | LLY Price Prediction) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two different playbooks for winning in healthcare.
Is It Worth Investing in Johnson & Johnson (JNJ) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
J&J's Innovative Medicine Business in Q2: Here's What to Watch
JNJ's Q2 Innovative Medicine results face scrutiny as Stelara biosimilar pressure offsets growth from key blockbusters and newer therapies ahead of earnings.
These 5 Passive Income Stocks Could Pay You For Life
Earned income demands your time. Passive income asks only that you stay invested.
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
J&J Wins CHMP Nod for Expanded Use of Multiple Myeloma Drug Tecvayli
JNJ gets a positive CHMP opinion for Tecvayli in combination with Darzalex SC for treating relapsed/refractory multiple myeloma after one prior therapy.
Johnson & Johnson (JNJ) Surges 4.0%: Is This an Indication of Further Gains?
Johnson & Johnson (JNJ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
How Much Of Your Dividend Income Do You Actually Get To Keep?
Dividend investors love clean numbers. A $1 million portfolio yielding 5% generates $50,000 a year, and it is tempting to treat that figure as spendable income. In reality, federal taxes, state taxes, Medicare premiums, and inflation all take their share before those dollars reach your checking account. Consider three retirees. Retiree A owns a $750,000... How Much Of Your Dividend Income Do You Actually Get To Keep?
Solvonis CEO on progress with potential alcohol use disorder treatment - ICYMI
Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) CEO, Anthony Tennyson, talked with Proactive about positive bridging pharmacokinetic (PK) data from the...
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
Johnson & Johnson (JNJ) concluded the recent trading session at $244.88, signifying a +1.61% move from its prior day's close.
One Stock to Own For Ultimate Dividend Safety
I keep hitting the buy button on Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) because I have stopped trying to find a more reliable income engine for the back half of my life.
Johnson & Johnson: Not Every Dollar Needs To Chase The AI Boom (Upgrade)
Johnson & Johnson (JNJ) is upgraded from Hold to Buy, driven by consistent performance, stable revenue growth, and defensive characteristics. JNJ trades at a 20x forward P/E, a justified 12% premium to peers, supported by above-industry margins and accelerating top-line growth. The company benefits from exposure to the expanding MedTech market, with potential for multiple expansion if bottom-line growth accelerates.
